Bio
Dr. Melinda Telli is an Associate Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine, Director of the Breast Cancer Program at the Stanford Cancer Institute and Associate Director of the Stanford Women's Cancer Center. Dr. Telli?s research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Her work has focused on the validation of homologous recombination deficiency biomarkers to help identify patients with sporadic triple-negative breast cancer that may specifically derive benefit from DNA repair defect-targeted therapies. In addition to her involvement in the clinical development of PARP inhibitors for BRCA1 and BRCA2 mutation-associated cancers, she has also explored the use of ?beyond BRCA? DNA repair gene mutations as potential biomarkers to select patients for PARP inhibitor therapy in the advanced disease setting.
Dr. Telli received her undergraduate degree from the University of Pennsylvania Magna Cum Laude and medical degree from George Washington University with Distinction. She completed internship and residency in Internal Medicine at Stanford University, and then stayed at Stanford to pursue fellowship training in Medical Oncology. She has served on numerous American Society of Clinical Oncology Committees and currently serves as a Komen Scholar, member of the National Comprehensive Cancer Network Breast Cancer Guideline Panel and member of the Journal of Clinical Oncology Editorial Board. Dr. Telli is the recipient of a Susan G. Komen for the Cure Translational Postdoctoral Fellowship Award (2008), American Society of Clinical Oncology Young Investigator Award (2009), Susan G. Komen for the Cure Leadership Award (2015 and 2018), Triple Negative Breast Cancer Foundation Hero Award (2018) and Komen SF Bay Area Visionary Award (2019). She has garnered multiple teaching accolades and is a repeat recipient of the Stanford Division of Oncology Teaching Award.
Clinical Focus
- Cancer > Breast Cancer
- Triple-negative breast cancer
- BRCA1 and BRCA2 mutation-associated breast cancer
- Hereditary breast cancer
- Metastatic breast cancer
- Locally advanced breast cancer
- Medical Oncology
Academic Appointments
-
Associate Professor - Med Center Line, Medicine - Oncology
-
Member, Stanford Cancer Institute
Administrative Appointments
-
Director, Breast Cancer Program, Stanford Cancer Institute (2020 - Present)
-
Associate Director, Stanford Women's Cancer Center, Stanford Cancer Institute (2020 - Present)
-
Leader, Breast Cancer Clinical Research Group, Stanford Cancer Institute (2018 - Present)
-
Breast Oncology Protocol Review Committee Co-Chair, Stanford Cancer Institute (2015 - 2018)
-
Komen Scholar, Susan G. Komen for the Cure (2015 - Present)
-
Breast Cancer Guidelines Panel, National Comprehensive Cancer Network (2014 - Present)
-
Scientific Review Committee, Stanford Cancer Institute (2016 - Present)
-
ASCO Breast Cancer Adjuvant Chemotherapy and Targeted Therapy Guideline Adaptation Panel, American Society of Clinical Oncology (2015 - Present)
-
Medical Oncology SEP Committee, American Board of Internal Medicine (2014 - 2017)
-
Breast Cancer Maintenance of Certification Working Group, American Society of Clinical Oncology (2013 - 2014)
-
Program Committee, ASCO Breast Cancer Symposium (2010 - 2013)
-
Scientific Program Committee, Triple Negative Breast Cancer/Cytotoxics/Local Therapy, American Society of Clinical Oncology (2010 - 2013)
Honors & Awards
-
Visionary Award, Susan G. Komen San Francisco Bay Area (2019)
-
Hero Award, Triple Negative Breast Cancer Foundation (2018)
-
San Francisco Bay Area Top Doctor, Medical Oncology, Castle Connolly (2017-2020)
-
Champion Award, Triple Step Toward the Cure (2015)
-
Komen Leadership Award, Susan G. Komen for the Cure (2015)
-
Nadia's Gift, Nadia's Gift Foundation (2015)
-
Career Catalyst Research Award, Susan G. Komen for the Cure (2012)
-
New Investigator Award, Stanford Cancer Institute (2011)
-
Oncology Division Teaching Award, Stanford University School of Medicine (2010, 2012, 2013, 2014)
-
Young Investigator Award, American Society of Clinical Oncology (2009)
-
Fellowship Award, Susan G. Komen for the Cure (2008)
-
Merit Award, American Society of Clinical Oncology (2008)
Professional Education
-
B.A., University of Pennsylvania, Biology, with Distinction (1996)
-
M.D., George Washington University, Medicine, with Distinction (2002)
-
Residency, Stanford University, Internal Medicine (2005)
-
Fellowship, Stanford University, Medical Oncology (2008)
-
Board Certification, American Board of Internal Medicine, Internal Medicine (2015)
-
Board Certification, American Board of Internal Medicine, Medical Oncology (2018)
-
Board Certification: American Board of Internal Medicine, Internal Medicine (2005)
-
Board Certification: American Board of Internal Medicine, Medical Oncology (2008)
Community and International Work
-
Susan G. Komen for the Cure
Location
International
Ongoing Project
No
Opportunities for Student Involvement
No
-
Facing Our Risk of Cancer Empowered (FORCE), Tampa, Florida
Location
US
Ongoing Project
Yes
Opportunities for Student Involvement
No
-
Bay Area Cancer Connections, Palo Alto, CA
Location
International
Ongoing Project
Yes
Opportunities for Student Involvement
No
-
Triple Step Toward the Cure, Mill Valley, CA
Location
California
Ongoing Project
Yes
Opportunities for Student Involvement
No